The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you
whenever you need it. Give us a call at
650-498-3333 or
PHYSICIAN HELPLINE
Have a question? We're here to help! Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
Vinicio de Jesus Perez MD
Pulmonologist, Pulmonary hypertenstion specialist, Critical care specialist, Interstitial lung disease specialist
Assistant Professor of Medicine (Pulmonary and Critical Care Medicine)
Bio:
Dr. Vinicio de Jesus Perez received his MD from the University of Puerto Rico Medical School and completed an internal medicine residency at Massachusetts General Hospital. He completed a fellowship in pulmonary and critical care medicine in Denver, followed by postdoctoral research training at Stanford University. He focused on researching genetic and molecular mechanisms of pulmonary hypertension (PH) and idiopathic pulmonary fibrosis (IPF) and has devoted his clinical practice to diagnosis and management of these conditions. He is presently assistant professor of medicine and staff physician of the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF. He is principal investigator of a research program with the ultimate goal of identifying new therapeutic targets to treat PH and IPF.
As a medical professional belonging to a minority group, Dr. de Jesus Perez is involved in academic endeavors seeking to improve access of care for patients with disadvantageous ethnic backgrounds and promote diversity in medicine.
As a medical professional belonging to a minority group, Dr. de Jesus Perez is involved in academic endeavors seeking to improve access of care for patients with disadvantageous ethnic backgrounds and promote diversity in medicine.
- 300 Pasteur Drive
- 1st Floor, Room A175
- Stanford, CA 94305
- Phone: 650-725-7061
Professional Education
- Fellowship: Univ Of Colorado (2004) CO
- Residency: Massachusetts General Hospital (2003) MA
- Internship: Massachusetts General Hospital (2001) MA
- Board Certification: Critical Care Medicine, American Board of Internal Medicine (2007)
- Board Certification: Pulmonary Disease, American Board of Internal Medicine (2006)
- Fellowship: Stanford University Medical Center (2006) CA
- Medical Education: University Of Puerto Rico (2000) PR
- MD, Stanford University, Pulmonary/CCM (2006)
- MD, University of Colorado-Denver, Pulmonary/CCM (2004)
- MD, Massachussetts General Hospital, Internal Medicine (2003)
- MD, University of Puerto Rico, Medicine (2000)
- BS, University of Puerto Rico, Biology (1996)
Honors & Awards
- Summa cum Laude-Biology, University of Puerto Rico (1996)
- Beta Beta Beta Award, Beta Beta Beta (1996)
- Summa cum Laude-Medicine, University of Puerto Rico (2000)
- Most Promising Young Profesional 2000, El Nuevo Dia (2000)
- Best Intern in Medicine, Massachusetts General Hospital (2001)
- Best Fellow, University of Colorado-Denver (2003)
- American Lung Association Postdoctoral Fellowship Award, American Lung Association (2006)
- Who's Who in Medicine in America 2007, Marquis Who's Who in America (2007)
- Finalist, Young Investigator Award, Stanford University Medical Center-Cardiovascular Institute (2007)
- Who's Who in America, Madison's Who's Who (2007)
- ATS 2007 Travel award, American Thoracic Society (2007)
- AHA 2007 Junior Investigator Travel Award, American Heart Association (2007)
- Oak Foundation Grant, Oak Foundation (2008)
- American Lung Association Career Development Award, American Lung Association (2008)
- AHA Scientific Sessions 2008 Best Basic Science Abstract, American Heart Association (2008)
- Career Development Program in the Genetics and Genomics of Lung Diseases (K12), NIH (2008)
- Fellow, Pulmonary Vascular Research Institute (2008)
- 2008 Professional of the year, Madison Who's who among pofessionals in America (2009)
- Finalist, BWF award, Burroughs Wellcome Fund (2009)
- ATS travel award, ATS (2009)
- Scholar, Harold Amos Career Development Award, Robert Wood Johnson Foundation (2010-2014)
- Member-at-large, Cardiopulmonary, Critical Care, Perioperative & Resuscitation Council, American Heart Association (2010-)
- Minority Travel Award, ATS (2010)
- Wall Center Genomics Research Grant, Vera Moulton Wall Center for Pulmonary Vascular Research (2011-2012)
- NIH Career Development Award (1 K08 HL105884-01), NIH (7/2012-7/2017)
- Fellow, American College of Chest Physicians (2012)
- OCT as a novel tool in the diagnosis of PAH, CBIS (2012-2013)
- Member, Scientific Research Committee, Pulmonary Hypertension Association (2012-)
- TRAM award, Translational Research and Applied Medicine Program, Stanford University (2012-2013)
- Editor, Case Reports in Clinical Medicine (2012-)
- Supplemental Award to Outstanding K08, Pulmonary Hypertension Association (2012-2017)
- Pulmonary Hypertension Breakthrough Initiative, CMREF (2012-)
- CVI seed grant, Stanford CVI (2013)
- Faculty Member, Faculty of 1000, Pulmonary Vascular Diseases (2013)
- Faculty Member, Faculty Row (2013)
- Be HEARD rare disease challenge award, Assay Depot/Sigma (2013-2015)
- American Lung Association Biomedical Research Grant, American Lung Association (2013-2015)
- Distinguished Faculty Fellow, Stanford University (2013)
- Keystone Symposia Fellowship, Keystone Symposia (2013)
- Fellow, American Heart Association, American Heart Association (2013)
- Member of the Planning Committee, 2014 Keystone Symposia Series, Keystone Symposia (2013-2015)
- The Role of Angiogenesis in Lung development, Stanford Child Health Research Institute (2014-2016)
- Faculty of 1000 Reviewer of the year, Faculty of 1000 Prime (2013)
- Stanford-Karolinska Institute Collaborative Award, Swedish Foundation for International Collaboration (2014-2016)
- Cournand and Comroe Award (mentor), American Heart Association (2014)
- Mentor, CHRI postdoctoral award, Stanford Child Health Research Institute (2015-2018)
- Primary Mentor, Hispanic-Serving Health Professions Schools (2015)
- Faculty of 1000 Faculty Member of the Year for Respiratory Disorders, Faculty of 1000 (2014)
- InterMune/Genentech Young Faculty Scholar in Pulmonary Fibrosis, Genentech (2015-2017)
- AHA Beginning Grant in Aid, American Heart Association (2015-2017)
- CHRI Pilot Study on LAM/TSC, Stanford CHRI (2015-2017)
- AHA Scientist Development Award (Mentor), American Heart Association (2015-2019)
- BeHeard 2015 Award for LAM Research, Rare Genomics Institute (2016-2017)
Administrative Appointments
- Staff Physician, Adult Pulmonary Hypertension Clinic (2006 - Present)
- Faculty Member, Stanford Cardiovascular Institute (2011 - Present)
- Assistant Professor of Medicine, Stanford University (2011 - Present)
- Faculty Member, CHRI (2012 - Present)
- Faculty Member, Bio-X (2012 - Present)
- Faculty Member, iBioinformatics (2015 - Present)
Publications
-
Optical Coherence Tomography of Pulmonary Arterial Walls in Humans and Pigs (Sus scrofa domesticus)
Brunner, N. W., Zamanian, R. T., Ikeno, F., Mitsutake, Y., Connolly, A. J., & Perez, V. A. J. (2015). Optical Coherence Tomography of Pulmonary Arterial Walls in Humans and Pigs (Sus scrofa domesticus). COMPARATIVE MEDICINE, 65(3), 217-224. -
Activation of the Wnt/Planar Cell Polarity Pathway Is Required for Pericyte Recruitment during Pulmonary Angiogenesis
Yuan, K., Orcholski, M. E., Panaroni, C., Shuffle, E. M., Huang, N. F., & Perez, V. A. J. (2015). Activation of the Wnt/Planar Cell Polarity Pathway Is Required for Pericyte Recruitment during Pulmonary Angiogenesis. AMERICAN JOURNAL OF PATHOLOGY, 185(1), 69-84. -
Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1
Ali, Z. A., Perez, V. D. J., Yuan, K., Orcholski, M., Pan, S., & Ashley, E. A. (2014). Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1. JOURNAL OF CLINICAL INVESTIGATION, 124(12), 5159-5174. -
Pumping it up! Angiogenesis and muscle deconditioning in pulmonary hypertension.
de Jesus Perez, V. A. (2014). Pumping it up! Angiogenesis and muscle deconditioning in pulmonary hypertension. American journal of respiratory and critical care medicine, 190(3), 250-251.
-
Targeting the Wnt signaling pathways in pulmonary arterial hypertension.
de Jesus Perez, V., Yuan, K., Alastalo, T.-P., Spiekerkoetter, E., & Rabinovitch, M. (2014). Targeting the Wnt signaling pathways in pulmonary arterial hypertension. Drug discovery today, 19(8), 1270-1276.
-
Whole-Exome Sequencing Reveals TopBP1 as a Novel Gene in Idiopathic Pulmonary Arterial Hypertension
Perez, V. A. J., Yuan, K., Lyuksyutova, M. A., Dewey, F., Orcholski, M. E., & Zamanian, R. T. (2014). Whole-Exome Sequencing Reveals TopBP1 as a Novel Gene in Idiopathic Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 189(10), 1260-1272.
-
Loss-of BMPR2 is Associated With Abnormal DNA Repair in Pulmonary Arterial Hypertension.
Li, M., Vattulainen, S., Aho, J., Orcholski, M., Rojas, V., & Alastalo, T. P. (2014). Loss-of BMPR2 is Associated With Abnormal DNA Repair in Pulmonary Arterial Hypertension. American journal of respiratory cell and molecular biology.
-
Loss of adenomatous poliposis coli-a3 integrin interaction promotes endothelial apoptosis in mice and humans.
de Jesus Perez, V. A., Yuan, K., Orcholski, M. E., Sawada, H., Zhao, M., & Rabinovitch, M. (2012). Loss of adenomatous poliposis coli-a3 integrin interaction promotes endothelial apoptosis in mice and humans. Circulation research, 111(12), 1551-1564.
-
BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways
Perez, V. A. J., Ali, Z., Alastalo, T.-P., Ikeno, F., Sawada, H., & Rabinovitch, M. (2011). BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways. JOURNAL OF CELL BIOLOGY, 192(1), 171-188.
-
Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways
Perez, V. A. J., Alastalo, T.-P., Wu, J. C., Axelrod, J. D., Cooke, J. P., & Rabinovitch, M. (2009). Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. JOURNAL OF CELL BIOLOGY, 184(1), 83-99.
-
First among Equals: Nerve Growth Factor in the Pathogenesis of Pulmonary Arterial Hypertension.
de Jesus Perez, V. A. (2015). First among Equals: Nerve Growth Factor in the Pathogenesis of Pulmonary Arterial Hypertension. American journal of respiratory and critical care medicine, 192(3), 274-275.
-
Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension
Chang, Y.-T., Tseng, C.-N., Tannenberg, P., Eriksson, L., Yuan, K., & Tran-Lundmark, K. (2015). Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension. CARDIOVASCULAR RESEARCH, 107(1), 20-31.
-
Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection
Jiang, X., Nguyen, T. T., Tian, W., Sung, Y. K., Yuan, K., & Nicolls, M. R. (2015). Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection. AMERICAN JOURNAL OF TRANSPLANTATION, 15(7), 1768-1781.
-
Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension.
Haddad, F., Spruijt, O. A., Denault, A. Y., Mercier, O., Brunner, N., & Zamanian, R. T. (2015). Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension. JACC. Cardiovascular imaging, 8(6), 627-638.
-
Suppression of endothelial CD39/ENTPD1 is associated with pulmonary vascular remodeling in pulmonary arterial hypertension.
Helenius, M. H., Vattulainen, S., Orcholski, M., Aho, J., Komulainen, A., & Alastalo, T.-P. (2015). Suppression of endothelial CD39/ENTPD1 is associated with pulmonary vascular remodeling in pulmonary arterial hypertension. American journal of physiology. Lung cellular and molecular physiology, 308(10), L1046-57.
-
MicroRNA and Cardiovascular Disease
Liao, X.-B., Perez, V. A. J., Krol, M., Yeh, C.-H., & Yuan, L.- qing. (2015). MicroRNA and Cardiovascular Disease. BIOMED RESEARCH INTERNATIONAL.
-
MicroRNA and Cardiovascular Disease
Liao, X.-B., de Jesus Perez, V., Krol, M., Yeh, C.-H., & Yuan, L.-Q. (2015). MicroRNA and Cardiovascular Disease. Biomed Research International.
-
Current Clinical Management of Pulmonary Arterial Hypertension
Zamanian, R. T., Kudelko, K. T., Sung, Y. K., Perez, V. D. J., Liu, J., & Spiekerkoetter, E. (2014). Current Clinical Management of Pulmonary Arterial Hypertension. CIRCULATION RESEARCH, 115(1), 131-147.
-
Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery.
Brunner, N., de Jesus Perez, V. A., Richter, A., Haddad, F., Denault, A., & Liao, X. (2014). Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery. Pulmonary circulation, 4(1), 10-24.
-
Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension
Sawada, H., Saito, T., Nickel, N. P., Alastalo, T.-P., Glotzbach, J. P., & Rabinovitch, M. (2014). Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension. JOURNAL OF EXPERIMENTAL MEDICINE, 211(2), 263-280.
-
Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery
Brunner, N. W. (2014). Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery. Pulmonary Circulation, 4(1).
-
FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.
Spiekerkoetter, E., Tian, X., Cai, J., Hopper, R. K., Sudheendra, D., & Rabinovitch, M. (2013). FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. journal of clinical investigation, 123(8), 3600-3613.
-
Understanding the pharmacokinetics of oral treprostinil in patients with pulmonary arterial hypertension.
de Jesus Perez, V. A. (2013). Understanding the pharmacokinetics of oral treprostinil in patients with pulmonary arterial hypertension. Journal of cardiovascular pharmacology, 61(6), 471-473.
-
MicroRNAs: promising therapeutic targets for the treatment of pulmonary arterial hypertension
Yuan, K., Orcholski, M., Tian, X., Liao, X., & Perez, V. A. J. (2013). MicroRNAs: promising therapeutic targets for the treatment of pulmonary arterial hypertension. EXPERT OPINION ON THERAPEUTIC TARGETS, 17(5), 557-564.
-
Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus.
Jiang, X., Hsu, J. L., Tian, W., Yuan, K., Olcholski, M., & Nicolls, M. R. (2013). Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus. Journal of molecular medicine (Berlin, Germany).
-
FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension
Spiekerkoetter, E. (2013). FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. Journal of Clinical Investigation, 123(8).
-
MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells.
Liao, X. B., Zhang, Z. Y., Yuan, K., Liu, Y., Feng, X., & Yuan, L. Q. (2013). MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells. Endocrinology.
-
A case of recurrent pericardial constriction presenting with severe pulmonary hypertension
Nathan Brunner, Krithika Ramachandran, Kristina T. Kudelko, Yon K. Sung, Edda Spiekerkoetter, & Vinicio de Jesus Perez. (2013). A case of recurrent pericardial constriction presenting with severe pulmonary hypertension. Pulmonary Circulation, 3(2).
-
Effectiveness of YouTube as a Source of Medical Information on Heart Transplantation.
Chen, H.- ming, Hu, Z.-K., Zheng, X.-L., Yuan, Z.-S., Xu, Z.-B., & Liao, X.-B. (2013). Effectiveness of YouTube as a Source of Medical Information on Heart Transplantation. Interactive journal of medical research, 2(2).
-
Safety and Efficacy of Transition from Systemic Prostanoids to Inhaled Treprostinil in Pulmonary Arterial Hypertension
Perez, V. A. J., Rosenzweig, E., Rubin, L. J., Poch, D., Bajwa, A., & Zamanian, R. T. (2012). Safety and Efficacy of Transition from Systemic Prostanoids to Inhaled Treprostinil in Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF CARDIOLOGY, 110(10), 1546-1550.
-
The Intersection of Genes and Environment Development of Pulmonary Arterial Hypertension in a Patient With Hereditary Hemorrhagic Telangiectasia and Stimulant Exposure
Ayala, E., Kudelko, K. T., Haddad, F., Zamanian, R. T., & Perez, V. de J. (2012). The Intersection of Genes and Environment Development of Pulmonary Arterial Hypertension in a Patient With Hereditary Hemorrhagic Telangiectasia and Stimulant Exposure. CHEST, 141(6), 1598-1600.
-
Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction
de Jesus Perez, V., Haddad, F, & Zamanian RT. (2012). Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction. Pulmonary Circulation.
-
Development of a recurrent pleural effusion in a patient with pulmonary arterial hypertension treated with imatinib
Olga M. Fortenko, Lana Melendres-Groves, Alice Richter, Xiaobo Liao, Edda Spiekerkoetter, & Vinicio A. De Jesus Perez. (2012). Development of a recurrent pleural effusion in a patient with pulmonary arterial hypertension treated with imatinib. Case Reports in Clinical Medicine, 1(2).
-
Characteristics and Outcome After Hospitalization for Acute Right Heart Failure in Patients With Pulmonary Arterial Hypertension
Haddad, F., Peterson, T., Fuh, E., Kudelko, K. T., Perez, V. D. J., & Zamanian, R. T. (2011). Characteristics and Outcome After Hospitalization for Acute Right Heart Failure in Patients With Pulmonary Arterial Hypertension. CIRCULATION-HEART FAILURE, 4(6), 692-699.
-
Pulmonary Hypertension Associated With Left Heart Disease: Characteristics, Emerging Concepts, and Treatment Strategies
Haddad, F., Kudelko, K., Mercier, O., Vrtovec, B., Zamanian, R. T., & Perez, V. D. J. (2011). Pulmonary Hypertension Associated With Left Heart Disease: Characteristics, Emerging Concepts, and Treatment Strategies. PROGRESS IN CARDIOVASCULAR DISEASES, 54(2), 154-167.
-
Disruption of PPAR gamma/beta-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival
Alastalo, T.-P., Li, M., Perez, V. D. J., Pham, D., Sawada, H., & Rabinovitch, M. (2011). Disruption of PPAR gamma/beta-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. JOURNAL OF CLINICAL INVESTIGATION, 121(9), 3735-3746.
-
Incidence, Correlates, and Consequences of Acute Kidney Injury in Patients With Pulmonary Arterial Hypertension Hospitalized With Acute Right-Side Heart Failure
Haddad, F., Fuh, E., Peterson, T., Skhiri, M., Kudelko, K. T., & Zamanian, R. T. (2011). Incidence, Correlates, and Consequences of Acute Kidney Injury in Patients With Pulmonary Arterial Hypertension Hospitalized With Acute Right-Side Heart Failure. JOURNAL OF CARDIAC FAILURE, 17(7), 533-539.
-
Chronic Thromboembolic Pulmonary Hypertension
Perez, V. A. J., & Zamanian, R. T. (2011). Chronic Thromboembolic Pulmonary Hypertension. NEW ENGLAND JOURNAL OF MEDICINE, 364(17), 1677-1677.
-
Disruption of the Apelin-APJ System Worsens Hypoxia-Induced Pulmonary Hypertension
Chandra, S. M., Razavi, H., Kim, Jm., Agrawal, R., Kundu, R. K., & Chun, H. J. (2011). Disruption of the Apelin-APJ System Worsens Hypoxia-Induced Pulmonary Hypertension. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 31(4), 814-U212.
-
Making Sense of the Estrogen Paradox in Pulmonary Arterial Hypertension
vinicio de jesus perez. (2011). Making Sense of the Estrogen Paradox in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine, 184.
-
Drugs and toxins-associated pulmonary arterial hypertension: lessons learned and challenges ahead.
de Jesus Perez, V., Kudelko, K., Snook, S., & Zamanian, R. T. (2011). Drugs and toxins-associated pulmonary arterial hypertension: lessons learned and challenges ahead. International journal of clinical practice. Supplement, (169), 8-10.
-
Epoprostenol-associated pneumonitis: Diagnostic use of a T-cell proliferation assay
Kudelko, K. T., Nadeau, K., Leung, A. N., Liu, J., Haddad, F., & Perez, V. D. J. (2010). Epoprostenol-associated pneumonitis: Diagnostic use of a T-cell proliferation assay. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 29(9), 1071-1075.
-
Cholinergic Modulation of Angiogenesis: Role of the 7 Nicotinic Acetylcholine Receptor
Wu, J. Cf., Chruscinski, A., Perez, V. A. J., Singh, H., Pitsiouni, M., & Cooke, J. P. (2009). Cholinergic Modulation of Angiogenesis: Role of the 7 Nicotinic Acetylcholine Receptor. JOURNAL OF CELLULAR BIOCHEMISTRY, 108(2), 433-446.
-
S100A4 and Bone Morphogenetic Protein-2 Codependently Induce Vascular Smooth Muscle Cell Migration via Phospho-Extracellular Signal-Regulated Kinase and Chloride Intracellular Channel 4
Spiekerkoetter, E., Guignabert, C., Perez, V. D. J., Alastalo, T.-P., Powers, J. M., & Rabinovitch, M. (2009). S100A4 and Bone Morphogenetic Protein-2 Codependently Induce Vascular Smooth Muscle Cell Migration via Phospho-Extracellular Signal-Regulated Kinase and Chloride Intracellular Channel 4. CIRCULATION RESEARCH, 105(7), 639-U37.
-
Angina Associated With Left Main Coronary Artery Compression in Pulmonary Hypertension
Perez, V. A. J., Haddad, F., Vagelos, R. H., Fearon, W., Feinstein, J., & Zamanian, R. T. (2009). Angina Associated With Left Main Coronary Artery Compression in Pulmonary Hypertension. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28(5), 527-530.
-
An antiproliferative BMP-2/PPAR gamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension
Hansmann, G., de Jesus Perez, V. A., Alastalo, T.-P., Alvira, C. M., Guignabert, C., & Rabinovitch, M. (2008). An antiproliferative BMP-2/PPAR gamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. JOURNAL OF CLINICAL INVESTIGATION, 118(5), 1846-1857.
-
Coexistence of Primary adenocarcinoma of the lung and Tsukamurella pneumonia: a case report and review of the literature
de Jesus Perez, Va., Swigris J, Ruoss, & S. (2008). Coexistence of Primary adenocarcinoma of the lung and Tsukamurella pneumonia: a case report and review of the literature. Journal of Medical Case Reports, 207(2).
-
Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation
Hansmann, G., Wagner, R. A., Schellong, S., Perez, V. A. J., Urashima, T., & Rabinovitch, M. (2007). Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. CIRCULATION, 115(10), 1275-1284.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Mar 2015
Dr. de Jesus Perez excellent & very informative. I really appreciated all the information he gave me -
SHC Patient, Dec 2014
Excellent.
SHC Patient, Nov 2014
Doctor Perez is my best guardian angel. He helps me to survive my serious illness. He so wonderful.
SHC Patient, Mar 2015
Dr. de Jesus Perez excellent & very informative. I really appreciated all the information he gave me -
SHC Patient, Dec 2014
Excellent.
SHC Patient, Nov 2014
Doctor Perez is my best guardian angel. He helps me to survive my serious illness. He so wonderful.